Skip to main content
Caplight Logo









HMNC Brain Health

HMNC Brain Health

Private
MunichHealthcare & Life Scienceshttps://www.hmnc-brainhealth.com/

Last Round

Series B

Jun 15, 2026

Total Funding Raised

$60.6M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

HMNC Brain Health is a clinical-stage biopharmaceutical company that develops personalized therapies for mental health disorders using AI-driven companion diagnostics and genomic insights.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Mental Health, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

precision psychiatrycompanion diagnosticsbiomarker-driven diagnosticspatient stratificationpersonalized medicineprecision medicinebiopharmaceutical developmentclinical trial optimizationmental health therapeuticsAI-driven diagnosticsdrug discoverydigital biomarkerspharma techmental health techAI in pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HMNC Brain Health Comparables

Compare HMNC Brain Health with similar companies based on industry and business-model similarity.

HMNC Brain Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Denovo Biopharma
82%
Circular Genomics
78%
Alto Neuroscience
78%

HMNC Brain Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 15, 2026
VC RoundOct 20, 2022
Convertible DebtJul 28, 2021

HMNC Brain Health Investors

Notable investors and investment history

HMNC Brain Health investors
InvestorRounds
Maschmeyer GroupSeries B
KundK-investVC Round
Jahr GroupVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 15, 2026

    $50M round led by MEDICE – The Health Family.

  • May 20, 2026

    Monthly visitors increased 84% MoM, reaching 3K.

HMNC Brain Health Filings

Explore SEC and related filing metadata, where available.

HMNC Brain Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HMNC Brain Health's valuation, stock price, and market status.

Is HMNC Brain Health a public or private company?

HMNC Brain Health is a private company.

What is the current stock price of HMNC Brain Health?

HMNC Brain Health is a private company, so its shares have no public market price. Caplight tracks HMNC Brain Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is HMNC Brain Health worth (valuation)?

Valuation information for HMNC Brain Health is not publicly available.

Can I buy HMNC Brain Health stock?

HMNC Brain Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was HMNC Brain Health's last funding round?

HMNC Brain Health's most recent funding round was Series B on June 15, 2026.

Who are the main investors in HMNC Brain Health?

Key investors in HMNC Brain Health include Jahr Group.

Will HMNC Brain Health IPO soon?

No public IPO plans have been announced for HMNC Brain Health.

How can I track HMNC Brain Health secondary market activity?

Caplight tracks bids, offers, and trades in HMNC Brain Health's shares on secondary markets.

Firmographic Details

HeadquartersMunich
Employee Range23
Year Founded2010
Last FundingJun 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?